Oncologist
October 2024
Background: Currently, treatment options for patients with advanced melanoma who experience failed immunotherapy or targeted therapy are lacking. Recent studies suggest the antitumor activity of combined pembrolizumab and lenvatinib in patients with advanced melanoma progressing on immunotherapy. Herein, we report the clinical outcomes of combined lenvatinib and a programmed cell death protein-1 inhibitor (PD-1) in this population.
View Article and Find Full Text PDFThe possibility of an autoparametric resonance in an isolated many-particle system induces a specific behavior of the particles in the presence of thermal noise. In particular, the variance associated with a resonant mode, and consequently that of the associated particles, is strongly increased compared to what it would have in the absence of parametric resonance. In this paper we consider a dimer submitted to a periodic potential for which there are only two modes, the center of mass motion and the internal vibration mode.
View Article and Find Full Text PDF